ArticleExperimental diabetes research2012

KU-32, a novel drug for diabetic neuropathy, is safe for human islets and improves in vitro insulin secretion and viability.

Kevin Farmer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.